NCT04704414

Brief Summary

This study investigates diagnostic methods to measure eyeball protrusion with a smartphone face scanner compared to the traditional Hertel exophthalmometer. The study aims to validate a new reliable, fast and convenient smartphone app to measure the protrusion of the eyeball in different diseases such as Graves' disease, orbital tumors, orbital fractures or orbital inflammation, as well as other rare diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 6, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 11, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

January 12, 2021

Status Verified

January 1, 2021

Enrollment Period

2.4 years

First QC Date

January 6, 2021

Last Update Submit

January 10, 2021

Conditions

Keywords

Hertel exophthalmometerexophthalmosface scannersmartphone

Outcome Measures

Primary Outcomes (4)

  • Accuracy of the smartphone face scanner

    Accuracy of iPhone exophthalmos measurements (measured in mm for each eye) compared to measure with 3D face scanner and Hertel Exophthalmometer

    On average 2 weeks

  • Test-retest-reliability of the smartphone face scanner

    Repeated measures (measured in mm for each eye) of the same subjects with iPhone 11, Hertel Exophthalmometer and 3D face scanner

    On average 2 weeks

  • Inter-operator reliability of the smartphone face scanner

    Measurement (measured in mm for each eye) of the same patients by 3 different operators

    On average 2 weeks

  • Smartphone face scanner measures before and after treatment with the smartphone face scanner

    Measurements (measured in mm for each eye) with the smartphone face scanner before and after exophthalmos-changing treatment

    On average 3 months

Study Arms (1)

Validation of smartphone face scanner

EXPERIMENTAL

Validation of smartphone face scanner in comparison to Hertel Exophthalmometer and high-definition face scanner.

Device: Exophthalmos measurement

Interventions

Exophthalmos measurement with iPhone 11 vs Artec Space Spider 3D Scanner vs Hertel Exophthalmometer.

Validation of smartphone face scanner

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • Able to cooperate with the study investigations (hearing, comprehension)
  • Exophthalmos (Grave's disease, orbital tumors, orbital inflammation, orbital fractures, rare causes (congenital, e.g. microphthalmos)
  • health controls

You may not qualify if:

  • Unable to sign informed consent
  • Unable to cooperate with the examinations (hearing loss, neurological deficits)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmology Department, University Hospital Zurich

Zurich, CH-8091, Switzerland

RECRUITING

MeSH Terms

Conditions

ExophthalmosGraves OphthalmopathyOrbital NeoplasmsOrbital Fractures

Condition Hierarchy (Ancestors)

Orbital DiseasesEye DiseasesEye Diseases, HereditaryGraves DiseaseGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGoiterThyroid DiseasesEndocrine System DiseasesHyperthyroidismAutoimmune DiseasesImmune System DiseasesSkull NeoplasmsBone NeoplasmsNeoplasms by SiteNeoplasmsEye NeoplasmsBone DiseasesMusculoskeletal DiseasesMaxillofacial InjuriesFacial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesSkull FracturesFractures, BoneWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Blinding of the operators of Hertel exophthalmometer for previous measurement results.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: * Accuracy and precision of smartphone in comparison with 3D face scanner and Hertel exophthalmometer * Test-retest reliability * Inter-operator reliability * Before and after exophthalmos-changing intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 6, 2021

First Posted

January 11, 2021

Study Start

August 14, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

January 12, 2021

Record last verified: 2021-01

Locations